nav.banner_textnav.banner_cta →
SwissNova Labs
Kisspeptin-10 research vial
SwissNova Labs
Kisspeptin-10 · 5mg
≥99% Purity · COA Included
Hormonal

Kisspeptin-10

Purity: 99%+
Size: 5mg
Grade: Research
Form: Lyophilized
✦
SwissNova Labs · Research Grade
Back to catalog
HormonalNEW!

Kisspeptin-10

Hypothalamic neuropeptide regulating GnRH and reproductive hormone axis.

GnRH stimulation — directly activates hypothalamic GnRH neurons for hormonal cascadeLH/FSH release — drives pituitary gonadotropin secretion for testosterone and fertility supportHPG axis regulation — master regulator of reproductive endocrine functionHormonal research — used in clinical studies for hypogonadism and fertility
$45.00
5mg · Research use only
Compound Specifications
Purity99%+
Molecular Weight1302.5 Da
Vial Size5mg
SequenceYNWNSFGLRF-NH2
Dosage Reference
Range50–100 mcg
FrequencyPulsatile dosing (every 90–120 min) or once daily
RouteSubcutaneous injection
Half-life~28 minutes
Vial Supply
Duration~10 weeks supply
Week 1Week 10

50 mcg/day

Why Researchers Choose This Compound

Key Benefits

01
GnRH stimulation

directly activates hypothalamic GnRH neurons for hormonal cascade

02
LH/FSH release

drives pituitary gonadotropin secretion for testosterone and fertility support

03
HPG axis regulation

master regulator of reproductive endocrine function

04
Hormonal research

used in clinical studies for hypogonadism and fertility

Administration Guide

Recommended Injection Sites

Optimal injection locations for Kisspeptin-10 based on its route (Subcutaneous injection) and pharmacokinetic profile.

Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.

Site Map — front

Tap a zone to inject

Best
Good
Acceptable
Primary Sites
Abdomen
Best
Periumbilical fat

Preferred SubQ site.

Secondary Sites
Thigh
Good
Anterolateral mid-thigh

Good alternative.

Needle Specs
Gauge27–29 gauge
Length5/16" – 1/2"
Angle45–90°
Site Rotation

Rotate sites each injection.

Avoid
  • IV administration without clinical supervision
Mechanism of Action

Active Signaling Pathway

Synergistic Protocols

Recommended Stacks

Kisspeptin-10 is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.

Fitness & Performance

Hormonal Vitality Stack

HPG axis activation and melanocortin optimization for vitality and libido research.

NEW!
Kisspeptin-10 — Primary — HPG axis activation
Activates GnRH neurons to drive LH and FSH release, stimulating natural testosterone production. The master upstream regulator of the reproductive endocrine axis.
8–12 weeksAdvanced3 compounds
View Full Stack →
Supply Calculator

How long will one vial last?

Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.

One vial lasts
10
weeks
That's approximately 2 months of continuous use at the standard protocol dose.
Reorder around week 9 to avoid running out
Your supply timeline5mg vial
Start↑ ReorderWeek 10 — empty
1
2
3
4
5
6
7
8
9
10
Active supplyReorder week
How we calculated this
5mg vial ÷ 50 mcg/day = 10 weeks of supply

Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.

Research Literature

Scientific Background

Mechanism of Action

Kisspeptin-10 binds the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, triggering pulsatile GnRH release. This activates the pituitary to secrete LH and FSH, which in turn stimulate gonadal steroidogenesis. It is the master regulator of the reproductive endocrine axis.

Clinical Context

Kisspeptin is now recognized as the primary upstream regulator of the HPG axis. Clinical trials are ongoing for its use in fertility treatment and hormonal disorders.

Research Highlights

  • Single IV dose shown to increase LH by 10–20× in healthy volunteers
  • Used in clinical research to diagnose and treat hypogonadotropic hypogonadism
  • Demonstrated role in puberty onset and fertility regulation
  • Research shows potential for testosterone optimization in males with secondary hypogonadism

Storage & Reconstitution

PROTOCOL NOTE

Pulsatile dosing mimics physiological GnRH release. Typical research cycle: 4–8 weeks.

RESEARCH USE ONLY:All products are sold strictly for in vitro research and laboratory use. Not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease or condition. By purchasing, you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.